Physician

Matthew L Lanternier, MD

According to 2025 Medicare claims, Matthew Lanternier, MD (NPI: 1437148285) practices family practice in the Iowa City, IA market, with the plurality of this provider's patient population coming from Johnson, IA. This provider's primary affiliated billing organization is STATE UNIVERSITY OF IOWA (NPI: 1477554814; TIN: 426004813) and primary practice location at 52245-2712. Lanternier is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Lanternier's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 385 traditional Medicare patients, billed 5,187 HCPCS/CPT codes, and received $136,510 in Medicare payments. The top billing code was 91320 (Sarscv2 vac 30mcg trs-suc im). Part D data shows 10,853 prescription claims across 517 beneficiaries totaling $723,060 in drug costs, led by Ozempic (Semaglutide). DME data shows 397 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $498,126 to $723,060. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $74,500 to $27,598.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	440	3,458	$118,072
2016	413	3,192	$100,853
2017	425	3,259	$100,182
2018	412	3,195	$101,847
2019	367	3,291	$112,631
2020	365	2,838	$95,243
2021	386	3,797	$127,406
2022	424	6,379	$133,736
2023	335	5,462	$124,762
2024	385	5,187	$136,510

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	411	10,930	$498,126
2016	391	10,787	$471,524
2017	391	9,501	$475,168
2018	424	9,558	$528,065
2019	420	9,170	$529,041
2020	397	8,726	$506,638
2021	403	9,058	$599,507
2022	456	9,266	$697,696
2023	452	9,652	$872,593
2024	517	10,853	$723,060

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	104	572	$24,033
2016	112	595	$18,218
2017	140	599	$16,912
2018	182	534	$13,182
2019	171	481	$11,973
2020	127	463	$15,316
2021	58	343	$16,195
2022	62	385	$28,975
2023	60	361	$18,051
2024	117	397	$21,496

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
91320	Sarscv2 vac 30mcg trs-suc im	128	150	$136
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	247	247	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	327	611	$75
90480	Admn sarscov2 vacc 1 dose	128	150	$40
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	227	332	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	151	4,566	$149,607
Eliquis	Apixaban	91	3,567	$69,500
Mounjaro	Tirzepatide	58	1,850	$69,200
Trulicity	Dulaglutide	54	1,592	$53,132
Jardiance	Empagliflozin	23	1,592	$31,895

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	25	$7,813
A7030	Full face mask used with positive airway pressure device, each	N	11	21	$2,085
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	13	29	$1,679
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	18	37	$1,523
A7031	Face mask interface, replacement for full face mask, each	N	N/R	20	$1,396

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Matthew L. Lanternier, MD?

Tedicare shows public-source Medicare data for Matthew L. Lanternier, MD (NPI 1437148285), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew L. Lanternier, MD have ACO affiliation data?

Matthew L. Lanternier, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Matthew L. Lanternier, MD?

Matthew L. Lanternier, MD is linked to STATE UNIVERSITY OF IOWA (billing NPI 1477554814) in the available physician profile data.

Does Matthew L. Lanternier, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.